about
The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.New single-nucleotide polymorphisms associated with differences in platelet reactivity and their influence on survival in patients with type 2 diabetes treated with acetylsalicylic acid: an observational study.Study design and rationale for biomedical shirt-based electrocardiography monitoring in relevant clinical situations: ECG-shirt study.Prevalence of depressive disorders in professional drivers - epidemiologic subanalysis of the RACER study.Anemia at Hospital Admission and Its Relation to Outcomes in Patients With Heart Failure (from the Polish Cohort of 2 European Society of Cardiology Heart Failure Registries).Diagnosis, Clinical Course, and 1-Year Outcome in Patients Hospitalized for Heart Failure With Preserved Ejection Fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry).Predictors of one-year outcome in patients hospitalised for heart failure: results from the Polish part of the Heart Failure Pilot Survey of the European Society of Cardiology.Resting heart rate at hospital admission and its relation to hospital outcome in patients with heart failure.Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran and rivaroxaban: results from the CRAFT study.OCULUS study: Virtual reality-based education in daily clinical practice.Heart failure patients with a previous coronary revascularization: results from the ESC-HF Registry.Appropriate and effective interventions of subcutaneous implantable cardioverter-defibrillator (S-ICD): single-academic-centre experience.The influence of the atrial fibrillation episode duration on the endothelial function in patients treated with pulmonary veins isolation.Do β-blockers improve one-year survival in heart failure patients with atrial fibrillation? Results from the ESC-HF RegistryCharakterystyka kliniczna i czynniki prognostyczne w rocznej obserwacji pacjentów z niewydolnością serca i migotaniem przedsionków w porównaniu z chorymi z niewydolnością serca i rytmem zatokowymClinical characteristics and thromboembolic risk of atrial fibrillation patients with and without congestive heart failure. Results from the CRATF studyHeart failure in elderly patients: differences in clinical characteristics and predictors of 1-year outcome in the Polish ESC-HF Long-Term RegistryDifferences in clinical characteristics and 1-year outcomes of hospitalized patients with heart failure in ESC-HF Pilot and ESC-HF-LT registriesComparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of CardiologyAssociation of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial InfarctionResistin is a prognostic factor for death in type 2 diabetes
P50
Q37602424-547C8C45-6212-4429-82D0-1BB55171456FQ37703289-93B7170C-075D-40A3-8655-3D7DFE9486E9Q38371680-502B1EAC-1647-4795-9DA0-917CBE8EE892Q39185030-BFDA038D-C2DA-48B4-9217-FE5F7970EB7FQ40231179-02F5F3E0-EDFF-4E72-9CC8-6D353966F2A3Q40668997-CAEF581C-FB80-4083-990D-16860619AB42Q41649231-4ADDEAF0-2BF0-42CD-8DFA-3DE75702AECFQ46123149-D7AF03B3-3B44-42B8-A885-CAC83C45021BQ47551351-417C0782-EEAE-4B9C-95F6-75D4ABBCCFE4Q49350112-989BBB33-6893-4D59-A4D7-033CBCE7D2B4Q49587776-31A7BC1C-AE79-4099-8AB0-E6CBC47A8D4EQ49852608-09C157DE-835F-4176-8D00-C58CCD99D6F7Q50736344-582D7201-E1F2-495D-A983-2B761118CE54Q57286226-0D56FEA8-E170-45FD-BAD8-0DD8549928C3Q57628529-4D0A7640-0C67-4F6A-A6B8-6811FA3B6762Q58567579-FD46A20C-2FE0-40BC-BF13-8ADAD50556ACQ88097558-63D3C3D6-F079-4862-A686-DCA7366D83BAQ91069450-A11B9940-FFAF-4D29-8AB1-42AF855CF59AQ91073360-7897D672-F1DD-4E85-AD09-5973F804805AQ91112793-26C48664-3646-432A-BDE7-3B5018B30672Q93186071-1A720B23-68F4-4C81-AEA1-21727472104B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Agata Tymińska
@en
Agata Tymińska
@nl
type
label
Agata Tymińska
@en
Agata Tymińska
@nl
prefLabel
Agata Tymińska
@en
Agata Tymińska
@nl
P31
P496
0000-0003-1381-302X